Publications
Detailed Information
Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Kyung-Hun | - |
dc.contributor.author | Lee, Ju-Hee | - |
dc.contributor.author | Han, Sae-Won | - |
dc.contributor.author | Im, Seock-Ah | - |
dc.contributor.author | Kim, Tae-You | - |
dc.contributor.author | Oh, Do-Youn | - |
dc.contributor.author | Bang, Yung-Jue | - |
dc.date.accessioned | 2021-01-31T11:06:46Z | - |
dc.date.available | 2021-01-31T11:06:46Z | - |
dc.date.created | 2020-12-23 | - |
dc.date.created | 2020-12-23 | - |
dc.date.created | 2020-12-23 | - |
dc.date.created | 2020-12-23 | - |
dc.date.issued | 2011-07 | - |
dc.identifier.citation | Cancer Science, Vol.102 No.7, pp.1388-1395 | - |
dc.identifier.issn | 1347-9032 | - |
dc.identifier.other | 119688 | - |
dc.identifier.uri | https://hdl.handle.net/10371/173031 | - |
dc.description.abstract | Heat shock protein 90 (HSP90) is a molecular chaperone required for the stability of key regulators of cell survival and is an emerging target of cancer therapy. NVP-AUY922, a novel and potent inhibitor of HSP90, was evaluated against gastric cancer cell lines. NVP-AUY922 significantly inhibited the proliferation of all tested gastric cancer cell lines with 50% inhibitory concentration in the range of 2-40 nM and potently induced the degradation of growth factor receptors and other client proteins including HER-2, Akt and thymidylate synthase. HSP70 was induced by NVP-AUY922 and its binding with client proteins led to their proteasomal degradation. Moreover, the combination of NVP-AUY922 with cytotoxic chemotherapeutic agents such as 5-fluorouracil and oxaliplatin created a synergistic effect. Taken together, these preclinical data demonstrate the potent activity of NVP-AUY922 against gastric cancer cells and offer a rationale for clinical development of the agent alone or in combination with other chemotherapeutic drugs to effectively treat gastric cancer. (Cancer Sci 2011; 102: 1388-1395) | - |
dc.language | 영어 | - |
dc.publisher | Oxford University Press | - |
dc.title | Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins | - |
dc.type | Article | - |
dc.contributor.AlternativeAuthor | 임석아 | - |
dc.identifier.doi | 10.1111/j.1349-7006.2011.01944.x | - |
dc.citation.journaltitle | Cancer Science | - |
dc.identifier.wosid | 000292863100021 | - |
dc.identifier.scopusid | 2-s2.0-79959313696 | - |
dc.citation.endpage | 1395 | - |
dc.citation.number | 7 | - |
dc.citation.startpage | 1388 | - |
dc.citation.volume | 102 | - |
dc.identifier.sci | 000292863100021 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Im, Seock-Ah | - |
dc.contributor.affiliatedAuthor | Kim, Tae-You | - |
dc.contributor.affiliatedAuthor | Oh, Do-Youn | - |
dc.contributor.affiliatedAuthor | Bang, Yung-Jue | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | HSP90 INHIBITOR | - |
dc.subject.keywordPlus | THYMIDYLATE SYNTHASE | - |
dc.subject.keywordPlus | MULTIPLE-MYELOMA | - |
dc.subject.keywordPlus | TUMOR-GROWTH | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | KINASE | - |
dc.subject.keywordPlus | LINES | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | GLIOBLASTOMA | - |
dc.subject.keywordPlus | CYTOTOXICITY | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.